Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALGRX 3268 for Venipuncture Pain in Pediatric Subjects
NCT00146185Phase 3Completed
- Sponsor
- AlgoRx Pharmaceuticals
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in procedural pain, sponsored by AlgoRx Pharmaceuticals. Started Feb 2005; status: completed.
02
Drugs
lidocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT00146185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146185.